EOCI has a demonstrated track record of over 13 years in the CME industry. Our reputation is a result of business integrity and professional agility, as well as resourcefulness and creativity.
In addition to the 25 to 30 CME programs we develop annually, EOCI produces other high-calibre specialist-focused annual congresses in Mont-Tremblant, and Montreal:
Stuart J. Connolly is a Professor of Medicine at McMaster University in Ontario and a Cardiac Electrophysiologist at Hamilton Health Sciences, Ontario. Dr. Connolly holds a Masters degree from Fordham University, New York, and an MD from McGill University in Montreal. He received his specialist training in cardiology at the University of Toronto and at Stanford University. Dr. Connolly became a faculty member at McMaster University in 1983 and was awarded a full professorship in 1994. As well as being an active clinical cardiologist, Dr. Connolly held the position of Director of the Division of Cardiology 2005-2015. He was also appointed as the inaugural holder of the Salim Yusuf Chair in Cardiology at McMaster University during that time.
Dr. Connolly has published more than 380 scientific articles in the field and is currently a member of the editorial boards for a number of prominent Cardiology journals, including Heart, the Journal of Pacing and Electrophysiology, and Journal of the American College of Cardiology. Dr. Connolly's main research interests are focused on the evaluation of treatments for heart rhythm disorders. His academic career has been largely devoted to the design and execution of controlled clinical trials in this area.
Dr. Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute.
Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He completed training in Internal Medicine, Clinical Pharmacology, and Cardiology at the University of Toronto and completed a Fellowship in Cardiac Electrophysiology at Stanford University.
He is a recipient of the University of Toronto Department of Medicine Research Award, and the Canadian Cardiovascular Society Achievement Award.
He is the Past-President of the Canadian Heart Rhythm Society, Chairman of the Cardiac Arrest Committee, St. Michael’s Hospital, Co-PI on the NIH funded Resuscitation Outcomes Consortium, head of the cardiac arrest committee of the Canadian Resuscitation Outcomes Consortium, and serves on the steering committee of multiple multicenter clinical trials in arrhythmia care. He is the Chair of the Canadian Cardiovascular Society Quality Committee.
His research interests include resuscitation science, sports cardiology, arrhythmias in athletes, basic science research in advanced cardiac life support and atrial fibrillation, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.
He was the principal investigator of the ALIVE RCT of antiarrhythmic drugs in cardiac arrest, the Family study on predicting and preventing sudden cardiac death , the CIHR funded EpiDOSE RCT, and the Program to reduce sudden death funded by the Canadian Arrhythmia Network.
He has published over 400 peer reviewed papers and is Associate Editor of the textbook Electrophysiological Disorders of the Heart.
Dr. L. Brent Mitchell obtained his BSc (Hon) in Biochemistry (1972) and his MD (1975) from the University of Calgary. After a Fellowship in Clinical Cardiology at Dalhousie University in Halifax, he undertook a Fellowship in Clinical Cardiac Electrophysiology at Stanford University Medical Center in California. He returned to Calgary in 1982. Dr. Mitchell is the former Head of the Department of Cardiac Sciences at the University of Calgary/Calgary Zone of Alberta Health Services, and the former Director of the Libin Cardiovascular Institute of Alberta.
Dr. Adrian Baranchuk, a native of Buenos Aires, Argentina, obtained his MD from the University of Buenos Aires in 1990. After qualifying in Internal Medicine and Cardiology (1995), he completed a Clinical Fellowship in Cardiac Electrophysiology (1997). In 2002, he immigrated to Spain, where he did a Research Fellowship. Dr. Baranchuk was appointed a Clinical Fellow in Electrophysiology at McMaster University in September 2003.
Dr. Baranchuk was appointed an Assistant Professor of Medicine at Queen’s University (2006), and was promoted to Associate Professor in 2010 and to Full Professor in 2016. He founded the EP Training Program in 2007.
He is a member of numerous editorial boards and a reviewer of several journals. He received a teaching award (Outstanding Contribution in the Core Internal Medicine Program, 2009) and the Faculty of Health Sciences Education Award in 2014. He is the editor in Chief of Journal of Electrocardiology and Deputy Editor of JACC in Spanish.
Dr. Baranchuk was awarded the Golden Caliper Award by SOLAECE (Latin American Society of Pacing and Electrophysiology) in 2014 for his outstanding contributions to science, and the ISHNE Junior Investigator Award in April 2015. He received also the "10 Most Influential Hispanic Canadian Award" in 2016.
His first book, Atlas of Advanced ECG Interpretation (Remedica , UK), represents a major collaboration of well-recognized electrophysiologists from around the world. His second book, Left Septal Fascicular Block, was released by Springer in 2016. His last iBook, Electrocardiography in Practice: What to do? was the no. 1 seller on iTunes for several weeks in 2016. His book Brugada Phenocopy: the Art of recognizing the Brugada ECG pattern was released by ELSEVIER this year. Clinical Arrhythmology 2nd Edition was published by Wiley and was written along Prof Bayes de Luna.
Dr. Baranchuk has published more than 545 articles in well-recognized international journals (463 in PubMed), as well as 40 book chapters. He has also presented more than 250 abstracts. He is President Elect of the International Society of Electrocardiology (ISE) for the period 2017-2019.
He lives in Kingston, Ontario, with his wife Barbara and his daughter Gala.
Beth Abramson MD is Associate Professor of Medicine at the U. of Toronto. She is the Paul Albrechtsen Professor in Cardiac Prevention and Women’s Health and director of the Cardiac Prevention and Rehabilitation Centre & Women’s Cardiovascular Health in the Division of Cardiology at St. Michael’s Hospital.
Dr. Abramson graduated from the U. of Toronto medical school. She trained in internal medicial in Toronto and completed a clinical cardiology fellowship at the Ottawa Heart Institute. She also completed a research fellowhip, during which she focused on evaluating issues related to women and heart disease. She has training in clinical epidemiology and a Masters of Health Administration from the University of Toronto. She holds fellowships in Internal Medicine from the American College of Physicians and the Royal College of Physicians and Surgeons of Canada in both Internal Medicine and Cardiology and is a Fellow of the American College of Cardiology.
She is actively involved in writing guidelines to educate physicians on preventive cardiology issues. She was a primary member of the 2000 CCS Consensus Conference on Women and Ischemic Heart Disease. In 2005 she co-chaired the CCS Consensus Conference on Peripheral Arterial Disease. She has been involved in writing national guidelines on menopause in collaboration with the SGOC, published in 2009, updated in 2013. In 2014 she co-authored Canadian guidelines for the diagnosis and management of stable ischemic heart disease.
She has been a member of the Heart and Stroke Foundation of Canada’s Health Policy and Promotion Committee (HPPAC). She was a founding member of the Heart Truth Leadership Council, which led a national awareness campaign for women and heart disease. She has an interest in gender equity. In 2010, she took a leadership role in the POWER Study addressing quality care in women. Dr. Abramson’s academic activities also include membership on the Admissions Committee for the U. of Toronto School of Medicine. She has been involved in the North American Menopause Societys’ (NAMS) awareness efforts. She is on the American College of Cardiology’s hypertension working group.
She is the 2018 chair of the Canadian Women's Heart Health Alliance Education group.
She spends much time educating the public on heart health and is a national spokesperson for the Heart and Stroke Foundation. Her book, Heart Health for Canadians, was published in Feb. 2013 to help people prevent and understand the issues related to heart disease.
In 2015 she was awarded the prestigious Harold N. Segal award of Merit, in recognition of her many contributions to preventing heart disease amongst Canadians.
Dr. Hisham Dokainish completed his undergraduate education and medical school at McMaster University, followed by Internal Medicine and Cardiology residency programs at the University of Ottawa. After completing an Echocardiography Fellowship at Vancouver General Hospital in 2002, he was hired as a faculty member at Baylor College of Medicine in Houston, Texas. He then returned to Canada in 2009 as Associate Professor of Medicine at McMaster University and Director of Echocardiography, as well as Director of the Medical Diagnostic Unit and Director of the Heart Failure Clinic at Hamilton Health Sciences. His interests include echocardiography, diastolic heart failure and valve disease. His sees outpatients in the new Cardiac Ambulatory Clinic at the Hamilton General Hospital, and is active in teaching and research at Hamilton Health Sciences/McMaster University.
John Eikelboom, MBBS, MSc, FRCPC is Associate Professor in the Department of Medicine, McMaster University, Senior Investigator, Population Health Research Institute and Haematologist at the Hamilton General Hospital, Ontario, Canada. He holds a Heart and Stroke Foundation Career Award and the Jack Hirsh/Population Health Research Institute Chair in Thrombosis and Atherosclerosis. Dr Eikelboom has co-authored more than 500 articles in peer-reviewed journals, and since 2014 has been listed annually among the top 1% of the most cited researchers globally in Clinical Medicine.
Robert G. Hart, M.D. led the stroke program at the University of Texas Health Sciences Center at San Antonio for 25 years before relocating to McMaster University in 2011. He is Professor of Medicine (Neurology) at McMaster University and is a Senior Scientist of Population Health Research Institute. Dr. Hart has long-standing interests in stroke prevention research and clinical trials. He has directed several randomized clinical trials serving as the principal investigator of the NIH/NINDS-sponsored Stroke Prevention in Atrial Fibrillation (SPAF) I, II and III trials (1987-2000) and has participated as a site lead investigator in more than a dozen others. Following completion of the SPAF trials, he was the co-principal investigator of the NIH/NINDS-sponsored Secondary Prevention of Small Subcortical Strokes (SPS3) trials. Between 2013-2018, he was the lead investigator for the large, international NAVIGATE-ESUS testing rivaroxaban in embolic strokes of uncertain source. Between 2000 and 2008, he was a special consultant to the NINDS/NIH Clinical Trials Group. Antithrombotic therapies to prevent stroke in atrial fibrillation (especially novel oral anticoagulants) and intracranial bleeding related to oral anticoagulants are areas of special interest.
Jeff Healey is the director of arrhythmia services at Hamilton Health Sciences, Professor of medicine at McMaster University and the Population Health Research Institute Chair in Cardiology Research. He is also the principal investigator and chair of the Canadian Stroke Prevention Intervention Network (CSPIN), which is conducting a series of clinical trials related to atrial fibrillation and stroke prevention. He is the past co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee and a founding member of the international AF-SCREEN organization. Dr. Healey was the lead author of the ASSERT trial, which was published in the New England Journal of Medicine in 2012 and demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers.
Dr. G.B. John Mancini is a tenured Professor of Medicine at the University of British Columbia, and directs an imaging-based research program (Cardiovascular Imaging Research Core Laboratory, CIRCL) that includes facilities for quantitative coronary angiography, ultrasound analysis (coronaries, carotids and brachial artery for atherosclerosis and endothelial function assessments) and cardiac computed tomography analysis. Dr. Mancini remains in active practice as a staff physician in the Vancouver Hospital as Director of the CardioRisk Clinic as well as at the St. Paul’s Hospital Healthy Heart Prevention Program/Lipid Clinic. He also serves as the Director of Research for the UBC Division of Cardiology.
Dr. Mancini received his MD degree from the University of Toronto, completed his residency at Toronto General Hospital and was a Cardiology and Research Fellow at the University of California at San Diego. After a year as Clinical Assistant Professor at U.C. San Diego, he joined the faculty of the University of Michigan, where he became Associate Chief of Cardiology and Chief of the V.A. Section of Cardiology in 1987. He was Chair of Medicine at the University of British Columbia from 1992 to 2002. He is a Fellow of the American College of Cardiology, Governor of the American College of Cardiology (British Columbia) and a member of the Circulation Council of the American Heart Association; he is also a member of numerous other professional associations in the United States and Canada. Dr. Mancini is a Past President of the Canadian Society for Clinical Investigation and past President of the Medical/Allied Staff of Vancouver Hospital. He has published over 300 journal articles, abstracts, books and book chapters. He serves as a reviewer for many journals, and is currently a member of the editorial boards of the American Journal of Cardiology, the Canadian Journal of Cardiology and the International Journal of Cardiac Imaging and Associate Editor of Atherosclerosis.
Dr. Mancini is currently Coordinating Investigator for the Cardiovascular Imaging Research Core Laboratory for numerous multi-centred trials. His areas of special interest include digital angiography, quantitative coronary angiography, quantitative intravascular ultrasound, quantitative carotid ultrasound, cardiac computed tomography, coronary flow reserve/fractional flow reserve, endothelial dysfunction, primary and secondary CV risk reduction and regression of atherosclerosis.
Dr. Morillo is a Cardiologist and Electrophysiologist and Professor in the Department of Cardiac Sciences, and Medicine, currently the Section Chief Cardiology Division at the Libin Caridovascular Institute of Alberta, Cumming School of Medicine, University of Calgary and Zone Head Cardiology for the Calgary & Southeastern Alberta Region, Alberta Health Services. He also holds and Adjunct Full Professor appointment at the Department of Medicine at McMaster University. Dr. Morillo was the Director of the Hamilton Atrial Fibrillation Reference Centre, Director of the Syncope Autonomic Disorder Unit at McMaster University (2002-2016).
Dr. Morillo is the past Director of the Arrhythmia & Pacing Services from 2002-2012. Dr. Morillo trained as a Cardiac electrophysiologist at the University of Western Ontario in London, Ontario Canada; he performed a post doctoral fellowship sponsored by the Heart & Stroke Foundation of Canada in Cardiovascular Autonomic Physiology, under the mentorship of Professor Dwain Eckberg. His main research interests are related with the development of clinical trials in the area of cardiac arrhythmias, syncope and treatment of Chagas Disease. Similarly he has done research in Cardiac autonomic regulation, sympathetic nerve traffic and baroreflex modulation in different diseases. He is internationally renowned in several fields that include atrial fibrillation, neurocardiogenic syncope, Chagas disease and clinical trials.
Dr. David Shu completed his training in endocrinology and metabolism at Dalhousie university in Halifax. He currently works as a staff endocrinologist at Royal Columbian hospital. He has an interest in teaching, serving as the discipline-specific site leader for medicine at RCH. He is also currently serving as the regional division head of endocrinology for the Fraser Health Authority.
Dr. Siegal is currently Assistant Professor in the Division of Hematology and Thromboembolism and Investigator at the Population Health Research Institute and Thrombosis and Atherosclerosis Institute at McMaster University. Her primary research interests include anticoagulant reversal and improving outcomes after anticoagulant-related bleeding complications. She has published over 45 articles in peer-reviewed journals including The New England Journal of Medicine, Annals of Internal Medicine, Circulation, Blood and Journal of Thrombosis and Haemostasis.
Dr. Virani is the Chief of Cardiology at Providence Health Care and Physician Program Director for the Provincial Heart Centre at St. Paul’s Hospital.
A key opinion leader for heart failure in Canada, Dr. Virani is the Heart Failure Physician Lead and Senior Medical Advisor at Cardiac Services BC, President of the Canadian Heart Failure Society as well as Associate Professor of Medicine at the University of British Columbia.
He completed his internal medicine and cardiology training at UBC before embarking on a sub-specialization in heart failure and cardiac transplantation at Stanford University. He also has a Master’s degree in Public Health from Columbia University with a focus on healthcare management. His professional interests include public policy related to health care delivery with specific reference to healthcare systems redesign and quality in the Canadian context.
Dr. Virani has authored a number of papers on chronic and acute decompensated heart failure, and is a principal investigator on numerous research trials.
He is Co-Chair of the Canadian Cardio-Oncology Guidelines and is a primary panelist on the Canadian Heart Failure Guidelines. He is Co-Chair of the Provincial Advisory Panel on Cardiac Health and past Co-Chair of British Columbia’s Specialist Services Committee – a collaboration between the Doctors of BC and BC’s Ministry of Health.
Receive the latest news on the Arrhythmia Update Conference directly in your mailbox.